Cited by 114Intensive Care Unit Cognitive DisordersAnesthesia and Sedative AgentsNosocomial Infections in ICU

Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: The multinational AID-ICU inception cohort study

Open access
Collet, Marie O., Caballero, Jesús, Sonneville, Romain, Bozza, Fernando A., Nydahl, Peter, Schandl, Anna, Wøien, Hilden, Citerio, Giuseppe +179 more·2018·Intensive Care Medicine

Abstract

Purpose We assessed the prevalence and variables associated with haloperidol use for delirium in ICU patients and explored any associations of haloperidol use with 90-day mortality.Methods All acutely admitted, adult ICU patients were screened during a 2-week inception period. We followed the patient throughout their ICU stay and assessed 90-day mortality. We assessed patients and their variables in the first 24 and 72 h in ICU and studied their association together with that of ICU characteristics with haloperidol use.Results We included 1260 patients from 99 ICUs in 13 countries. Delirium occurred in 314/1260 patients [25% (95% confidence interval 23-27)] of whom 145 received haloperidol [46% (41-52)]. Other interventions for delirium were benzodiazepines in 36% (31-42), dexmedetomidine in 21% (17-26), quetiapine in 19% (14-23) and olanzapine in 9% (6-12) of the patients with delirium. In the first 24 h in the ICU, all subtypes of delirium [hyperactive, adjusted odds ratio (aOR) 29.7 (12.9-74.5); mixed 10.0 (5.0-20.2); hypoactive 3.0 (1.2-6.7)] and circulatory support 2.7 (1.7-4.3) were associated with haloperidol use. At 72 h after ICU admission, circulatory support remained associated with subsequent use of haloperidol, aOR 2.6 (1.1-6.9). Haloperidol use within 0-24 h and within 0-72 h of ICU admission was not associated with 90-day mortality [aOR 1.2 (0.5-2.5); p = 0.66] and [aOR 1.9 (1.0-3.9); p = 0.07], respectively.Conclusions In our study, haloperidol was the main pharmacological agent used for delirium in adult patients regardless of delirium subtype. Benzodiazepines, other anti-psychotics and dexmedetomidine were other frequently used agents. Haloperidol use was not statistically significantly associated with increased 90-day mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00134-018-5204-y

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hyperactive delirium most often comes to clinical attention, but the mixed and hypoactive presentations are far more common.

    “Hyperactive delirium most often comes to clinical attention, but the mixed and hypoactive presentations are far more common [7,59,60,61].”

    From Psychological and Psychiatric Comorbidities in Youth with Serious Physical Illness (2022) · cites this paper as [60]

    The Background says mixed and hypoactive delirium are more common than hyperactive delirium, and the Delirium results report 13.1% mixed and 5.7% hypoactive versus 6.1% hyperactive among ICU patients. The paper does not establish that hyperactive delirium most often comes to clinical attention. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 45 · Cited by 114

Authors
Collet, M. O., Caballero, J., Sonneville, R., Bozza, F. A., Nydahl, P., Schandl, A., Wøien, H., Citerio, G., van den Boogaard, M., Hästbacka, J., Haenggi, M., Colpaert, K., Rose, L., Barbateskovic, M., Lange, T., Jensen, A., Krog, M. B., Egerod, I., Nibro, H. L., Wetterslev, J., Perner, A., co-authors, T. A.-I. C. S., Agrifoglio, A., Patruno, A., Kalioubie, A. E., Lautrette, A., Miguel, A., Molinari, A. F., Toniolo, A., Rodt, A. P., Skafte, A. A., Nissen, A. K., Naharro, A., Berg, A. M. N., Estébanez, García, B., Encina, B., Bundgaard, B. S., Rossen, B. S., Sjoeboe, B. A., Díaz, C., Bäckman, C., Leggieri, C., de Cabo, C. M., Pavo-Galán, C., Gutiérrez, C., Tingsvik, C., Rousseau, C., Kjer, C. K. W., Almeida, C., Cantaroni, C., de Oliveira, C. C., Escudero, Pretorius, D., Hees, D., Manzanedo, D., Mamaev, D., Christensen, D., Skorstad, E. M., Lappi, E., Wiborg, E., Siven, E., Perecmanis, E., Sauter, E., De Lucas, E. H., Cabeza, E. F., Aakerman, E., Lovisari, F., Vagginelli, F., Näsström, F., Schiöler, F., Moreno-Gonzalez, G., Martelli, G., Gimeno, G., Tanaskovic, G., Ramos, G. V., Abusdal, G., Aagaard, G., Jensen, H. I., Knudsen, H., Bundgaard, H., Hoffmeyer, H., Torrado, H., Aguirre-Bermeo, H., Pérez-Moltó, H., Jara, de Haas, I., Baerentsen, I. D., Finnstroem, I. J., Greve, I. E., Ceniceros, I., Savia, I., Astola, I., Elkjaer, J. M., Mira, J.-P., Palm, J. L., Soini, J., Olsson, J. E., Nyberg, J., Heinonen, J., Alonso, J., García, J. M. G., Masclans, Jr., Goyeneche, J. M., Corral, J. M., Pilypaite, J., Bye, K., Saarinen, K., Wian, K.-A., Weber, K., Donadello, K., Kangas, K., Simons, K. S., Lundholm, L., Malchiodi, L., Álvarez, L., Han-Byul, L., Rabello, L. S. C. F., von Holck, L., Loisa, P., Buus, L., Christensen, L. J., Dall’ara, L., Melkersson, L., Orwelius, L., De Crop, L., Antoine, M., Santafé, M., Sánchez, M., Blackwell, M. L., Cronhjort, M., Martínez, M., Martín-Delgado, M. C., Levin, M., Maus, M., Henry-Lagarrigue, M., Romera, M. A., Välimäki, M., Bernal, M. H., Ramon, N., Baeza, N., Maquigneau, N., Marin, N., Moeller-Nielsen, N., Terzi, N., Glerup, O., Vinorum, O., Inkinen, O., Hild, P., Miquel-Diego, P., Rood, P., de Azambuja Rodrigues, P. M., Ernoe, P. E., Baadstoeloekken, P. M., Holm, P., Haltia, P., Ferrer, R., Hansen, R., Yano, R., Medici, R., da Silva, R. T. A., Smonig, R., Frederiksen, R., Sardo, S., Sutinen, S., Kentala, S., Besset, S., Sant’Anna, S. T., Rodríguez, S., Zambelli, S. E., Contreras, S., Pedersen, S., Hüfner, S., Leggio, S., Balsliemke, S., Gaudry, S., Estrup, S., Temprano, S., Nielsen, S., van Zuylen, T., Suhonen, T., Melms, T., Heinicke, T., Zinzoni, V., Blázquez-Alcaide, V., Jørgensen, V. L., & Collado, Z.
Affiliations
  • Copenhagen University Hospital (DK)
  • Universitat Autònoma de Barcelona (ES)
  • Inserm (FR)
  • Ministério da Saúde (BR)
  • University Hospital Schleswig-Holstein (DE)
  • Karolinska University Hospital (SE)
  • Oslo University Hospital (NO)
  • University of Milano-Bicocca (IT)
  • University of Helsinki (FI)
  • Ghent University Hospital (BE)
  • Sunnybrook Health Science Centre (CA)
  • University of Copenhagen (DK)
  • Aarhus University Hospital (DK)
Corresponding author
Collet, Marie O.
Venue
Intensive Care Medicine
Published
2018-05-16
Volume
44
Issue
7
Pages
1081-1089
ISSN
  • 0342-4642 (ISSN-L)
  • 1432-1238
OpenAlex
W2803806834
Cited by
114
References
45
Citations by year
2026: 8 · 2025: 9 · 2024: 11 · 2023: 36 · 2022: 9 · 2021: 14 · 2020: 7 · 2019: 17 · 2018: 3
FWCI
8.57
Type
journal article
Language
en
Open access
Locations
  • Intensive Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion, other-oa)
  • Työväentutkimus Vuosikirja (submittedVersion, other-oa)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • Open Access CRIS of the University of Bern
Funders
Innovation Foundation Denmark
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
Keywords
haloperidol, delirium, intensive care unit patients, delirium prevalence, delirium risk factors, 90-day mortality, benzodiazepines, dexmedetomidine, quetiapine, olanzapine, delirium subtypes, circulatory support, antipsychotic use
MeSH terms
Adolescent, Adult, Brazil, Canada, Critical Care, Delirium, Europe, Haloperidol, Humans, Intensive Care Units, Prospective Studies, Risk Factors, Antipsychotic Agents, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review